Table 1.
Model | Full name | Country, year | Formula |
---|---|---|---|
FLI [10] | Fatty Liver Index | Italy, 2006 | FLI = e 0.953 × ln TG + 0.139 × BMI + 0.718 × ln (GGT) + 0.053 × WC − 15.745)/(1 + e 0.953 × ln TG + 0.139 × BMI + 0.718 × ln (GGT) + 0.053 × WC − 15.745) × 100 |
FLD [14] | Fatty liver disease index | China, 2013 | FLD index = BMI + TG + 3 (ALT/AST ratio) + 2HG (presence of HG, HG = 1; absence of HG, HG = 0) |
ZJU [15] | Zhejiang University index | China, 2015 | ZJU index = BMI + FPG + TG + 3 ALT/AST ratio + 2 (if female) |
LAP [12] | Lipid accumulation product | Italy, 2010 | LAP (male) = (WC – 65) × TG LAP (female) = (WC – 58) × TG |
CAP [16] | Regression formula of controlled attenuation parameter | China, 2018 | CAP = 113.163 + 0.252 × ALT + 6.316 × BMI |
WHtR [9] | Waist-to-Height Ratio | Japan, 1995 | WHtR = WC/height × 100 |
TyG [11] | Triglyceride and glucose index | Mexico, 2008 | TyG = ln[(TG × FPG)/2] |
VAI [13] | Visceral adiposity index | Italy, 2012 | VAI (male) = (WC/(39.68 + (1.88 × BMI))) × (TG/1.03) × (1.31/HDL-C) VAI (female) = (WC/(39.58 + (1.89 × BMI))) × (TG/0.81) × (1.52/HDL-C) |
ALT, alanine aminotransferase; AST, aspartic transaminase; BP, blood pressure; DM, diabetes mellitus; FPG, fasting plasma glucose; GGT, gamma-glutamyl transpeptidase; HG, hyperglycemia; HDL-C, high-density lipoprotein cholesterol; TG, triglyceride; TB, total bilirubin; TC, total cholesterol; WC, waist circumference; platelet count.